{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:57:17Z","timestamp":1791554237766,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43321-1","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:54:26Z","timestamp":1773316466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Machine-learning prediction and risk stratification of 12-month cognitive decline in Alzheimer\u2019s disease using routine clinical and MRI data"],"prefix":"10.1038","volume":"16","author":[{"given":"Yinghui","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"43321_CR1","doi-asserted-by":"publisher","unstructured":"Alzheimer\u2019s, A. Alzheimer\u2019s disease facts and figures. Alzheimers Dement.  20(5), 3708\u20133821.  https:\/\/doi.org\/10.1002\/alz.13809 (2024).","DOI":"10.1002\/alz.13809"},{"issue":"1","key":"43321_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal. Transduct. Target. Ther. 9(1), 211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"7","key":"43321_CR3","doi-asserted-by":"publisher","first-page":"110263","DOI":"10.1016\/j.isci.2024.110263","volume":"27","author":"S Zhang","year":"2024","unstructured":"Zhang, S. et al. Alzheimer\u2019s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle Study of Aging. Machine learning on longitudinal multi-modal data enables the understanding and prognosis of Alzheimer\u2019s disease progression. iScience 27(7), 110263. https:\/\/doi.org\/10.1016\/j.isci.2024.110263 (2024).","journal-title":"iScience"},{"issue":"1","key":"43321_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12967-024-05025-w","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Alzheimer\u2019s Disease Neuroimaging Initiative. Predicting long-term progression of Alzheimer\u2019s disease using a multimodal deep learning model incorporating interaction effects. J. Transl Med. 22(1), 265. https:\/\/doi.org\/10.1186\/s12967-024-05025-w (2024).","journal-title":"J. Transl Med."},{"issue":"1","key":"43321_CR5","doi-asserted-by":"publisher","first-page":"12276","DOI":"10.1038\/s41598-024-60134-2","volume":"14","author":"MW Lee","year":"2024","unstructured":"Lee, M. W. et al. A multimodal machine learning model for predicting dementia conversion in Alzheimer\u2019s disease. Sci. Rep. 14(1), 12276. https:\/\/doi.org\/10.1038\/s41598-024-60134-2 (2024).","journal-title":"Sci. Rep."},{"key":"43321_CR6","doi-asserted-by":"publisher","unstructured":"Collins, G. S. et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 385, e078378. Erratum in: BMJ 385, q902. https:\/\/doi.org\/10.1136\/bmj-2023-078378.  https:\/\/doi.org\/10.1136\/bmj.q902 (2024).","DOI":"10.1136\/bmj-2023-078378"},{"key":"43321_CR7","doi-asserted-by":"publisher","first-page":"e074819","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. Evaluation of clinical prediction models (part 1): from development to external validation. BMJ 384, e074819. https:\/\/doi.org\/10.1136\/bmj-2023-074819 (2024).","journal-title":"BMJ"},{"issue":"1","key":"43321_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41398-024-02819-w","volume":"14","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. A multimodal deep learning approach for the prediction of cognitive decline and its effectiveness in clinical trials for Alzheimer\u2019s disease. Transl Psychiatry. 14(1), 105. https:\/\/doi.org\/10.1038\/s41398-024-02819-w (2024).","journal-title":"Transl Psychiatry"},{"issue":"1185","key":"43321_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/postmj\/qgae027","volume":"100","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Understanding decision curve analysis in clinical prediction model research. Postgrad. Med. J. 100(1185), 512\u2013515. https:\/\/doi.org\/10.1093\/postmj\/qgae027 (2024).","journal-title":"Postgrad. Med. J."},{"key":"43321_CR10","doi-asserted-by":"publisher","unstructured":"Vickers, A. J., Van Calster, B., Wynants, L. & Steyerberg, E. W. Decision curve analysis: confidence intervals and hypothesis testing for net benefit. Diagn Progn Res. 7:11. https:\/\/doi.org\/10.1186\/s41512-023-00148-y (2023). Correction in: Diagn Progn Res. 9(1), 8. https:\/\/doi.org\/10.1186\/s41512-025-00188-6 (2025).","DOI":"10.1186\/s41512-023-00148-y"},{"issue":"16","key":"43321_CR11","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/healthcare11162244","volume":"11","author":"D Piovani","year":"2023","unstructured":"Piovani, D., Sokou, R., Tsantes, A. G., Vitello, A. S. & Bonovas, S. Optimizing Clinical Decision Making with Decision Curve Analysis: Insights for Clinical Investigators. Healthc. (Basel). 11(16), 2244. https:\/\/doi.org\/10.3390\/healthcare11162244 (2023).","journal-title":"Healthc. (Basel)"},{"issue":"3","key":"43321_CR12","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/alz.13565","volume":"20","author":"V Devanarayan","year":"2024","unstructured":"Devanarayan, V. et al. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI). Predicting clinical progression trajectories of early Alzheimer\u2019s disease patients. Alzheimers Dement. 20(3), 1725\u20131738. https:\/\/doi.org\/10.1002\/alz.13565 (2024).","journal-title":"Alzheimers Dement."},{"issue":"6","key":"43321_CR13","doi-asserted-by":"publisher","first-page":"fcae445","DOI":"10.1093\/braincomms\/fcae445","volume":"6","author":"C Birkenbihl","year":"2024","unstructured":"Birkenbihl, C., de Jong, J., Yalchyk, I. & Fr\u00f6hlich, H. Deep learning-based patient stratification for prognostic enrichment of clinical dementia trials. Brain Commun. 6(6), fcae445. https:\/\/doi.org\/10.1093\/braincomms\/fcae445 (2024).","journal-title":"Brain Commun."},{"issue":"1","key":"43321_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/alz.13449","volume":"20","author":"DP Veitch","year":"2024","unstructured":"Veitch, D. P. et al. Alzheimer\u2019s Disease Neuroimaging Initiative. The Alzheimer\u2019s Disease Neuroimaging Initiative in the era of Alzheimer\u2019s disease treatment: A review of ADNI studies from 2021 to 2022. Alzheimers Dement. 20(1), 652\u2013694. https:\/\/doi.org\/10.1002\/alz.13449 (2024).","journal-title":"Alzheimers Dement."},{"issue":"1","key":"43321_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41467-022-35712-5","volume":"14","author":"E Maheux","year":"2023","unstructured":"Maheux, E. et al. Forecasting individual progression trajectories in Alzheimer\u2019s disease. Nat. Commun. 14(1), 761. https:\/\/doi.org\/10.1038\/s41467-022-35712-5 (2023).","journal-title":"Nat. Commun."},{"issue":"1","key":"43321_CR16","doi-asserted-by":"publisher","first-page":"e14321","DOI":"10.1002\/alz.14321","volume":"21","author":"MW Weiner","year":"2025","unstructured":"Weiner, M. W. et al. Alzheimer\u2019s Disease Neuroimaging Initiative. Overview of Alzheimer\u2019s Disease Neuroimaging Initiative and future clinical trials. Alzheimers Dement. 21(1), e14321. https:\/\/doi.org\/10.1002\/alz.14321 (2025).","journal-title":"Alzheimers Dement."},{"issue":"9","key":"43321_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","volume":"81","author":"S Janelidze","year":"2024","unstructured":"Janelidze, S. et al. Plasma Phosphorylated Tau 217 and A\u03b242\/40 to Predict Early Brain A\u03b2 Accumulation in People Without Cognitive Impairment. JAMA Neurol. 81(9), 947\u2013957. https:\/\/doi.org\/10.1001\/jamaneurol.2024.2619 (2024).","journal-title":"JAMA Neurol."},{"issue":"8","key":"43321_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA 324(8), 772\u2013781. https:\/\/doi.org\/10.1001\/jama.2020.12134 (2020).","journal-title":"JAMA"},{"issue":"10","key":"43321_CR19","doi-asserted-by":"publisher","first-page":"7320","DOI":"10.1002\/alz.14099","volume":"20","author":"AW Toga","year":"2024","unstructured":"Toga, A. W., Neu, S., Sheehan, S. T. & Crawford, K. Alzheimer\u2019s Disease Neuroimaging Initiative. The informatics of ADNI. Alzheimers Dement. 20(10), 7320\u20137330. https:\/\/doi.org\/10.1002\/alz.14099 (2024).","journal-title":"Alzheimers Dement."},{"key":"43321_CR20","doi-asserted-by":"publisher","first-page":"e074820","DOI":"10.1136\/bmj-2023-074820","volume":"384","author":"RD Riley","year":"2024","unstructured":"Riley, R. D. et al. Evaluation of clinical prediction models (part 2): how to undertake an external validation study. BMJ 384, e074820. https:\/\/doi.org\/10.1136\/bmj-2023-074820 (2024).","journal-title":"BMJ"},{"key":"43321_CR21","first-page":"4765","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Lee, S-I. A unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. (NeurIPS). 30, 4765\u20134774 (2017).","journal-title":"Adv. Neural Inf. Process. Syst. (NeurIPS)"},{"key":"43321_CR22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.csbj.2024.08.005","volume":"24","author":"D Muhammad","year":"2024","unstructured":"Muhammad, D. & Bendechache, M. Unveiling the black box: A systematic review of Explainable Artificial Intelligence in medical image analysis. Comput. Struct. Biotechnol. J. 24, 542\u2013560. https:\/\/doi.org\/10.1016\/j.csbj.2024.08.005 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"9","key":"43321_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/jamia\/ocad088","volume":"30","author":"AH van der Vegt","year":"2023","unstructured":"van der Vegt, A. H. et al. Implementation frameworks for end-to-end clinical AI: derivation of the SALIENT framework. J. Am. Med. Inf. Assoc. 30(9), 1503\u20131515. https:\/\/doi.org\/10.1093\/jamia\/ocad088 (2023).","journal-title":"J. Am. Med. Inf. Assoc."},{"issue":"11","key":"43321_CR24","doi-asserted-by":"publisher","first-page":"e2342203","DOI":"10.1001\/jamanetworkopen.2023.42203","volume":"6","author":"C Yuan","year":"2023","unstructured":"Yuan, C., Linn, K. A. & Hubbard, R. A. Algorithmic Fairness of Machine Learning Models for Alzheimer Disease Progression. JAMA Netw. Open. 6(11), e2342203. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.42203 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"1","key":"43321_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3233\/ADR-230194","volume":"8","author":"T Chithiramohan","year":"2024","unstructured":"Chithiramohan, T. et al. Culture-Fair Cognitive Screening Tools for Assessment of Cognitive Impairment: A Systematic Review. J. Alzheimers Dis. Rep. 8(1), 289\u2013306. https:\/\/doi.org\/10.3233\/ADR-230194 (2024).","journal-title":"J. Alzheimers Dis. Rep."},{"issue":"8","key":"43321_CR26","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3390\/ijerph21081110","volume":"21","author":"E Gkintoni","year":"2024","unstructured":"Gkintoni, E. & Nikolaou, G. The Cross-Cultural Validation of Neuropsychological Assessments and Their Clinical Applications in Cognitive Behavioral Therapy: A Scoping Analysis. Int. J. Environ. Res. Public. Health. 21(8), 1110. https:\/\/doi.org\/10.3390\/ijerph21081110 (2024).","journal-title":"Int. J. Environ. Res. Public. Health"},{"issue":"1","key":"43321_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12916-024-03252-y","volume":"22","author":"YG Rykov","year":"2024","unstructured":"Rykov, Y. G. et al. Predicting cognitive scores from wearable-based digital physiological features using machine learning: data from a clinical trial in mild cognitive impairment. BMC Med. 22(1), 36. https:\/\/doi.org\/10.1186\/s12916-024-03252-y (2024).","journal-title":"BMC Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43321-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:27:02Z","timestamp":1776090422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43321"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43321-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a secondary analysis of de-identified data from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database. The ADNI study was approved by the Institutional Review Board of the University of Southern California (USC) and by the institutional review boards of all participating sites. All procedures were conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and U.S. 21 CFR Part 50 and Part 56. Written informed consent was obtained from all participants at each site. As this study used de-identified secondary data with no direct interaction with participants, no additional ethical approval was required for the present study. Further details on ADNI ethics approvals are available at\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"12227"}}